Harvard University is challenging the freezing of $2 billion in federal funds, accusing the Trump administration of retaliation after refusing to change practices related to anti-Semitism.
Andreea Lificiu
International
Credit editorial: Postmodern Studio / Shutterstock.com
Always see our news on Google
The lawsuit filed by Harvard seeks to freeze $2 billion in federal funds, a decision made by the Trump administration in response to the Trump administration's rejection of requests to change university practices to combat anti-Semitism. Judge Allison Burroughs could overturn those freezes, revitalizing the university's scholarly research. Harvard is seeking summary judgment, and a decision could go all the way to the US Supreme Court.
Sources
Harvard a ajuns în instanţă, contra Administraţiei Trump. Miza procesului: 2.6 miliarde de dolari | Newsweek Romania
Hearing begins in Harvard's case against the Trump administration
Universitatea Harvard se va prezenta la tribunal în procesul de 2,6 miliarde de dolari împotriva administrației Trump
The Latest: Harvard heads to court in $2.6B lawsuit against Trump administration
Harvard heads to court to argue Trump administration's $2.6bn in cuts were illegal
Harvard and Trump lawyers take funding fight to court
Trump administration live updates: Judge to hear arguments in Harvard University lawsuit over research funding cuts
Harvard is hoping court rules Trump administration's $2.6B research cuts were illegal
Latest News
08:06
The U.S. Treasury debt has reached $40.047 trillion, exceeding CBO estimates. The rapid increase in the deficit raises concerns in the financial markets.
07:59
The Washington Post: Russians withdraw billions from banks, fearing that Putin will confiscate their deposits to finance his war
07:46
Hungary: The construction of a riverbed threshold on the Danube has raised the water level by 15-20 cm, preventing the shutdown of the turbines at the Paks nuclear power plant.
07:45
Kiev was the target of a new attack with Russian ballistic missiles. At least six people have died and 12 have been injured.
07:37
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
